title: Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.
abstract: This manuscript reports the consensus statements regarding the design and conduct of clinical trials in patients with newly diagnosed and recurrent epithelial ovarian cancer (EOC), following deliberation at the Fifth Ovarian Cancer Consensus Conference (OCCC), held in Tokyo in November 2015. Three important questions were identified for discussion prior to the meeting and achieved consensus during the meeting: (i) What are the most important factors to be evaluated prior to initial therapy? (ii) What are the most important factors to be evaluated specifically in recurrent disease? (iii) Are there specific considerations for special patient subpopulations? In addition, we report a list of important unmet needs compiled during the consensus process, which is intended to guide future research initiatives.
authors.affiliation: CCTG, Kingston, Canada.
authors.forename: J
authors.initials: J
authors.lastname: McGee
authors.affiliation: GOG, Philadelphia, USA.
authors.forename: M
authors.initials: M
authors.lastname: Bookman
authors.affiliation: AGO, Wiesbaden, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Harter
authors.affiliation: AGO-AU, Innsbruck, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Marth
authors.affiliation: MRC/NCRI, London, UK.
authors.forename: I
authors.initials: I
authors.lastname: McNeish
authors.affiliation: GOG, Philadelphia, USA.
authors.forename: K N
authors.initials: KN
authors.lastname: Moore
authors.affiliation: GEICO, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Poveda
authors.affiliation: AGO, Wiesbaden, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Hilpert
authors.affiliation: GOTIC, Saitama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Hasegawa
authors.affiliation: GCIG, Kingston, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Bacon
authors.affiliation: ECOG-ACRIN, Philadelphia, USA.
authors.forename: C
authors.initials: C
authors.lastname: Gatsonis
authors.affiliation: ANZGOG, Camperdown, Australia-New Zealand.
authors.forename: A
authors.initials: A
authors.lastname: Brand
authors.affiliation: BGOG, Leuven, Belgium.
authors.forename: F
authors.initials: F
authors.lastname: Kridelka
authors.affiliation: COGi, Stanford, USA.
authors.forename: J
authors.initials: J
authors.lastname: Berek
authors.affiliation: EORTC-GCG, Brussels, Belgium.
authors.forename: N
authors.initials: N
authors.lastname: Ottevanger
authors.affiliation: ISGO, Holon, Israel.
authors.forename: T
authors.initials: T
authors.lastname: Levy
authors.affiliation: JGOG, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Silverberg
authors.affiliation: KGOG, Seoul, Republic of Korea.
authors.forename: B-G
authors.initials: BG
authors.lastname: Kim
authors.affiliation: CCTG, Kingston, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Hirte
authors.affiliation: JGOG, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Okamoto
authors.affiliation: CCTG, Kingston, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Stuart
authors.affiliation: JGOG, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ochiai
mesh_terms: D000077216:Carcinoma, Ovarian Epithelial; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy*; D057285:Precision Medicine / Q000379:methods*
keywords: GCIG; consensus conference; individualized therapy; ovarian cancer; recommendations